Pallas Capital Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-11,585
| Closed | -$2.53M | – | 607 |
|
|
2024
Q2 | $2.53M | Buy |
11,585
+647
| +6% | +$141K | 0.11% | 135 |
|
|
2024
Q1 | $2.96M | Buy |
10,938
+5,295
| +94% | +$1.43M | 0.12% | 131 |
|
|
2023
Q4 | $1.33M | Sell |
5,643
-4,441
| -44% | -$1.05M | 0.07% | 175 |
|
|
2023
Q3 | $1.66M | Buy |
10,084
+415
| +4% | +$68.3K | 0.1% | 151 |
|
|
2023
Q2 | $2.02M | Buy |
9,669
+2,016
| +26% | +$422K | 0.09% | 125 |
|
|
2023
Q1 | $1.56M | Buy |
7,653
+421
| +6% | +$85.8K | 0.15% | 106 |
|
|
2022
Q4 | $1.76M | Sell |
7,232
-57
| -0.8% | -$13.9K | 0.18% | 99 |
|
|
2022
Q3 | $1.58M | Buy |
7,289
+672
| +10% | +$146K | 0.18% | 97 |
|
|
2022
Q2 | $1.57M | Buy |
+6,617
| New | +$1.57M | 0.22% | 82 |
|
|
2021
Q4 | – | Sell |
-729
| Closed | -$283K | – | 357 |
|
|
2021
Q3 | $283K | Sell |
729
-227
| -24% | -$88.1K | 0.03% | 316 |
|
|
2021
Q2 | $398K | Buy |
+956
| New | +$398K | 0.06% | 219 |
|